PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Breast Neoplasms
Interventions
DRUG

PF-06804103

Dose Escalation Part - 1A Dose Expansion Part - 2A

DRUG

PF-06804103 + Palbociclib +Letrozole

Dose Escalation - Part 1B Dose Expansion - Part 2B

Trial Locations (46)

2050

Chris O'Brien Lifehouse, Camperdown

2109

Macquarie University, Macquarie Park

10408

National Cancer Center, Goyang-si

13620

Seoul National University Bundang Hospital, Seongnam-si

20089

Istituto Clinico Humanitas U. O. Oculistica, Milan

20133

Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan

20141

Divisione di Cardiologia - Istituto Europeo di Oncologia Divisione di Medicina Nucleare, Milan

Istituto Europeo di Oncologia, Milan

20900

Azienda Socio-Sanitaria Territoriale Monza, Monza

21565

Gachon University Gil Medical Center, Incheon

28040

Hospital Universitario Fundación Jiménez Díaz, Madrid

28050

Hospital Universitario HM Sanchinarro, Madrid

28223

Hospital Universitario Quirón Madrid, Pozuelo de Alarcón

30033

Northside Hospital, Inc.-GCS/Stemmer, Decatur

30041

Atlanta Cancer Care - Cumming, Cumming

30046

Suburban Hematology-Oncology Associates- Lawrenceville, Lawrenceville

30060

Northside Hospital, Inc. GCS/Kennestone, Marietta

30096

Suburban Hematology-Oncology Associates - Duluth, Duluth

30114

Northside Hospital, Inc. - GCS/Canton, Canton

30236

Atlanta Cancer Care - Lake Spivey, Jonesboro

30342

Atlanta Cancer Care - Atlanta, Atlanta

Northside Hospital, Inc. - GCS/Northside, Atlanta

Northside Hospital, Atlanta

30512

Northside Hospital,Inc.-GCS /Blairsville, Blairsville

30606

Northside Hospital Inc.- GCS/Athens, Athens

31217

Northside Hospital, Inc. - GCS/Macon, Macon

68130

Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha

77030

The University of Texas MD Anderson Cancer Center, Houston

84112

University of Utah, Huntsman Cancer Hospital, Salt Lake City

University of Utah, Huntsman Cancer Institute, Salt Lake City

85719

Banner-University Medical Center Tucson, Tucson

The University of Arizona Cancer Center - North Campus, Tucson

85724

The University of Arizona Cancer Center, Tucson

90048

Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles

90095

UCLA Health (main campus), Los Angeles

UCLA Hematology/Oncology, Los Angeles

90404

Santa Monica - UCLA Medical Center and Orthopaedic Hospital, Santa Monica

UCLA Dept of Medicine - Hematology/Oncology, Santa Monica, Santa Monica

UCLA Health, Santa Monica, Santa Monica

195271

"Private Healthcare Institution Clinical hospital RZD-Medicine of Saint-Petersburg", Saint Petersburg

357502

"LLC Clinica UZI 4D", Pyatigorsk

03080

Seoul National University Hospital, Seoul

03722

Severance Hospital, Yonsei University Health System, Seoul

06351

Samsung Medical Center, Seoul

08035

Hospital Universitario Vall d'Hebron, Barcelona

08036

Hospital Clinic de Barcelona, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03284723 - PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors | Biotech Hunter | Biotech Hunter